China's industrial development master plan accelerates the integration of precision medical industry
As the development plan of China's industrial general program, the "Guidelines for the Development of Pharmaceutical Industry" was officially released by the six ministries and commissions of the country, aiming to guide the transformation of China's pharmaceutical industry from large to strong and the improvement of drug quality. The evaluation of the consistency of quality and efficacy, the acceleration of industrial integration and the enhancement of international competitiveness will become the major events in the development of China's pharmaceutical industry.
The industry believes that in this context, pharmaceutical companies with excellent research and development capabilities or sustained and steady growth in performance are worthy of investors' attention.
Five key words of medical development
The "Guide" basically predicts the path of the development of the pharmaceutical industry in the next five years. Innovation, quality, integration, greenness and internationalization have become the five key words for China's pharmaceutical industry from the big to the strong.
Increasing R&D investment is an important path to achieve R&D innovation. The Guide hopes that by 2020, the R&D investment intensity of enterprises above designated size in the whole industry will reach 2% or more. In fact, the R&D investment of multinational pharmaceutical companies is generally above 10%.
The Guide proposes to further provide a benign development ecosystem for R&D and innovation through the construction of pharmaceutical manufacturing innovation centers, small and micro enterprise innovation and entrepreneurship service platforms, pharmaceutical industry venture capital plans, pharmaceutical R&D data and public resource platforms. First of all, carry out cooperation around the common development of industrial development and key technical issues, and achieve 10-15 key technological breakthroughs. Second, guide social capital to set up more than 50 pharmaceutical industry venture capital funds, with a total scale of more than 10 billion yuan.
The consistency of quality and efficacy of generic drugs is an important way to improve the quality of drugs. The Guide requires the completion of the consistency assessment task for national essential pharmaceutical oral solid preparations during the planning period. With the attention of the state, this important task once written in the "Twelfth Five-Year Plan" is expected to be completed during the "Thirteenth Five-Year Plan" period. In addition, the cultivation of a large number of large-scale products with sales exceeding 2 billion yuan is also the focus of this plan. The purpose is to change the situation of homogenization of products and low market concentration, and promote the improvement of quality and safety level and industrial upgrading.
The improvement of international competitiveness is an important step in the formulation of Chinese preparations from large to strong. The internationalization strategy of preparations mentioned in the Guide includes: supporting the construction of a number of high-standard preparation production bases, and achieving more than 100 GMP certifications in the “13th Five-Year Plan†period, but currently there are only more than 60. It can realize 3-5 new drugs and more than 200 chemical generic drugs listed in developed countries. At the same time, the Guide supports enterprises to acquire or invest in the construction of overseas chemical raw materials, preparations, and Chinese herbal medicine production bases, promote international cooperation in production capacity, make full use of overseas environmental resources, and better serve the local market.
An obvious trend in the Guide is to accelerate the integration of the industry, continuously improve industry concentration and achieve green development. The goal is to increase the proportion of the top 100 enterprises' main business income by 10% by 2020, and the leading role of large enterprises in the development of the industry will be further strengthened.
Hospital Nitrile Gloves,Exam Nitrile Gloves,Nitrile Gloves Bulk,Medical Hand Gloves Powder Free
Puyang Linshi Medical Supplies Co., Ltd. , https://www.linshihealths.com